Discovery of novel 4-indolyl triazolo[1,5-a]pyrimidine derivatives as highly potent reversal agents against ABCB1-mediated multidrug resistance
Chinese Chemical Letters · 2026-07 · 113260
DOI: 10.1016/j.cclet.2026.113260 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chinese Chemical Letters, 2026-07. Verfasst von Wen-Bo Liu und 7 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben. Gefördert von: Natural Science Foundation of Henan Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Natural Science Foundation of Henan Province
- National Natural Science Foundation of China
Zitieren
APA
Liu, W., Fu, X., Li, N., Chen, B., Niu, J., Wang, Y., Song, J., & Zhang, S. (2026). Discovery of novel 4-indolyl triazolo[1,5-a]pyrimidine derivatives as highly potent reversal agents against ABCB1-mediated multidrug resistance. Chinese Chemical Letters, 113260. https://doi.org/10.1016/j.cclet.2026.113260
Vancouver
Liu W, Fu X, Li N, Chen B, Niu J, Wang Y, et al. Discovery of novel 4-indolyl triazolo[1,5-a]pyrimidine derivatives as highly potent reversal agents against ABCB1-mediated multidrug resistance. Chinese Chemical Letters. 2026:113260. doi:10.1016/j.cclet.2026.113260
BibTeX
@article{Liu2026,
author = {Liu, Wen-Bo and Fu, Xiang-Jing and Li, Na and Chen, Bing-Bing and Niu, Jin-Bo and Wang, Yan-Yan and Song, Jian and Zhang, Sai-Yang},
title = {Discovery of novel 4-indolyl triazolo[1,5-a]pyrimidine derivatives as highly potent reversal agents against ABCB1-mediated multidrug resistance},
journal = {Chinese Chemical Letters},
year = {2026},
pages = {113260},
doi = {10.1016/j.cclet.2026.113260}
}
EUVIMED